Department of Pediatrics, Faculdade de Medicina da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
J Pediatr Gastroenterol Nutr. 2014 May;58(5):598-602. doi: 10.1097/MPG.0000000000000255.
The aim of the present study was to evaluate the treatment adherence of children with chronic functional constipation.
The present study is a prospective and longitudinal study realized at a pediatric gastroenterology clinic of a Brazilian University Hospital, between August 2009 and October 2011. Rome III criteria and the Bristol Stool Scale were used to define constipation and to characterize feces, respectively. Drug treatment was prescribed for patients according to the protocols previously standardized in the clinic. Specific questionnaires, containing questions related to 1 dependent variable and independent variables were completed in the first and sixth months of the treatment. Independent variables related to the patients, their caregivers, the disease itself, and the therapeutic plan were analyzed and compared with the dependent variable (adherence to the treatment). Adherence was considered when the patient returned with >75% of the prescribed medicine containers empty.
Fifty children participated in both the first and sixth months of treatment. The mean age of the sample was 77.6 ± 43.8 months and the mean age of the onset of symptoms was 18.8 ± 27.9 months. The adherence rate was 38% in the first month and 30% in the sixth month. Patients who were treated with polyethylene glycol had greater adherence than patients who were prescribed other laxatives, with statistical significance in the second moment of the study (P = 0.19 and P = 0.04, respectively).
The study showed low adherence rates to drug treatment of constipation in children. It is necessary to seek new strategies to increase treatment adherence, while avoiding complications and reducing costs.
本研究旨在评估慢性功能性便秘儿童的治疗依从性。
本研究为前瞻性、纵向研究,于 2009 年 8 月至 2011 年 10 月在巴西一家大学医院的儿科胃肠病学诊所进行。Rome III 标准和布里斯托尔粪便量表分别用于定义便秘和粪便特征。根据诊所先前标准化的方案,为患者开具药物治疗。在治疗的第 1 个月和第 6 个月,填写包含 1 个因变量和独立变量相关问题的特定问卷。分析与因变量(治疗依从性)相关的患者、其照顾者、疾病本身和治疗计划等独立变量,并进行比较。当患者返回时,若其携带的处方药容器剩余量超过 75%,则认为其具有治疗依从性。
共有 50 名儿童参与了治疗的第 1 个月和第 6 个月。样本的平均年龄为 77.6 ± 43.8 个月,症状开始的平均年龄为 18.8 ± 27.9 个月。第 1 个月的依从率为 38%,第 6 个月为 30%。与使用聚乙二醇的患者相比,使用其他泻药的患者具有更高的依从性,在研究的第二阶段具有统计学意义(P = 0.19 和 P = 0.04)。
本研究显示儿童便秘药物治疗的依从率较低。有必要寻求新的策略来提高治疗依从性,同时避免并发症和降低成本。